Practices

Bar Admissions

Jayson Cohen is an associate in the firm’s Intellectual Property Group. Mr. Cohen focuses his practice on patent litigation and other intellectual property litigation and counseling.

Mr. Cohen has extensive experience in all stages of IP litigation—from pre-filing investigation, the pleading stage, and preliminary injunction practice to discovery and trial—as well as extensive experience negotiating and drafting settlements. He has represented clients before numerous U.S. District Courts, the New York Supreme Court, the U.S. International Trade Commission, and the U.S. Copyright Royalty Board in patent infringement, IP licensing, and trade secret disputes. These disputes have spanned a wide variety of technologies, such as:

Beyond his work in litigating IP disputes, Mr. Cohen has served as IP litigation counsel for transactional matters, such as acquisitions and securities offerings, and he has counseled corporate clients and hedge funds interested in understanding existing IP litigations and IP law.

Prior to his legal career, Mr. Cohen gained extensive professional experience in numerous technology areas, which he uses in his IP practice. These technology areas include electronics, optics, physics, communications, networks, cryptography, chemistry, mechanical devices, and software. He worked as a scientist at MagiQ Technologies, Inc. from 2000 to 2001, where he also acted as the liaison with outside counsel on patent and regulatory issues. From 2001 to 2004, he worked as a senior engineer at The MITRE Corporation. In addition, Mr. Cohen was a visiting scientist at New York University in 1999 and at the National Science Foundation FOCUS Center at the University of Michigan from 2004 to 2006. Mr. Cohen is also an inventor on two patents, one concerning efficient random number generation using optical detection and one concerning wavevector-division multiplexed optical communications and quantum cryptography.

Mr. Cohen writes regularly on IP-related topics. He authored the chapter “Settling Patent Cases” in a leading treatise on the law of settlement agreements and the settlement process, Settlement Agreements in Commercial Disputes: Negotiating, Drafting and Enforcement. He was a Contributing Editor of another leading treatise, Trade Secrets, for which he focused on developments in the law of misappropriation of trade secrets. Furthermore, Mr. Cohen has served on the Publications Committee of the New York Intellectual Property Law Association (NYIPLA) since 2013. For NYIPLA’s bi-monthly publication, TheReport (formerly Bulletin), he writes a regular feature entitled “IP Media Links.”

In 2015, Mr. Cohen was named a BTI Client Service All-Star by corporate counsel in recognition of his excellence in client service, one of only 354 lawyers and 25 IP lawyers named nationally. From 2012-2015, he was selected by Super Lawyers to the New York-Metro Rising Stars list for Intellectual Property Litigation.

Mr. Cohen earned a Sc.B. in electrical engineering and an A.B. in history magna cum laude from Brown University, where he was elected to Tau Beta Pi. He received his Ph.D. in applied physics from the University of Michigan, where he was a Regents Fellow and a Rackham Pre-Doctoral Fellow. He received his J.D. magna cum laude from the University of Michigan Law School, where he served as a contributing editor of the Michigan Law Review and was elected to the Order of the Coif.

Mr. Cohen is registered to practice before the United States Patent and Trademark Office.

(Southern District of New York). Represented AETN against a non-practicing entity accusing A&E’s online programming schedule of patent infringement. After successfully moving to transfer the case from Chicago to New York, the case settled on favorable terms.

(District of New Jersey). Represented Sandoz Inc. in patent litigations under the Hatch-Waxman Act involving formulations of the active pharmaceutical ingredient palonosetron, a treatment for emesis. Settled favorably before trial.

MediaTek Inc. v. Freescale Semiconductor, Inc.

(Northern District of California). Represented Freescale Semiconductor in patent litigation involving bus architecture and arbitration in system-on-a-chip circuits and power management of processors in those circuits.

Alcorn Communications, LLC v. Marketwire, Inc.

(Southern District of New York). Represented Marketwire (a/k/a Marketwired) against a non-practicing entity in patent litigation involving Internet news releases.

(Central District of California). Represented Genentech and City of Hope against Glaxo and Human Genome Sciences in patent litigations involving the Cabilly II and III patents and monoclonal antibody products Arzerra® (ofatumumab) and Benlysta® (belimumab). Filed the first case asserting the Cabilly III patent. The Arzerra® cases settled with Glaxo taking a license under the Cabilly II and III patents. The Benlysta® cases settled on undisclosed terms.

(Middle District of North Carolina). Represented BASF against generic manufacturers in patent litigations involving the chemical synthesis and use of the insecticide fipronil and use of the industry-leading fipronil-containing termiticide Termidor®. Cheminova agreed to remain out of the U.S. market until the expiration of a BASF manufacturing patent, and Makhteshim agreed not to use BASF’s patented manufacturing processes to make fipronil.

(District of New Jersey). Represented Estèe Lauder in patent litigation involving cosmetic formulations. Settled after favorable Markman ruling from the bench led to undisputed non-infringement defense against one of the two patents-in-suit.

(Southern District of New York). Represented AETN against a non-practicing entity accusing A&E’s online programming schedule of patent infringement. After successfully moving to transfer the case from Chicago to New York, the case settled on favorable terms.

(District of New Jersey). Represented Sandoz Inc. in patent litigations under the Hatch-Waxman Act involving formulations of the active pharmaceutical ingredient palonosetron, a treatment for emesis. Settled favorably before trial.

MediaTek Inc. v. Freescale Semiconductor, Inc.

(Northern District of California). Represented Freescale Semiconductor in patent litigation involving bus architecture and arbitration in system-on-a-chip circuits and power management of processors in those circuits.

Alcorn Communications, LLC v. Marketwire, Inc.

(Southern District of New York). Represented Marketwire (a/k/a Marketwired) against a non-practicing entity in patent litigation involving Internet news releases.

(Central District of California). Represented Genentech and City of Hope against Glaxo and Human Genome Sciences in patent litigations involving the Cabilly II and III patents and monoclonal antibody products Arzerra® (ofatumumab) and Benlysta® (belimumab). Filed the first case asserting the Cabilly III patent. The Arzerra® cases settled with Glaxo taking a license under the Cabilly II and III patents. The Benlysta® cases settled on undisclosed terms.

(Middle District of North Carolina). Represented BASF against generic manufacturers in patent litigations involving the chemical synthesis and use of the insecticide fipronil and use of the industry-leading fipronil-containing termiticide Termidor®. Cheminova agreed to remain out of the U.S. market until the expiration of a BASF manufacturing patent, and Makhteshim agreed not to use BASF’s patented manufacturing processes to make fipronil.

(District of New Jersey). Represented Estèe Lauder in patent litigation involving cosmetic formulations. Settled after favorable Markman ruling from the bench led to undisputed non-infringement defense against one of the two patents-in-suit.

In 2015, Mr. Cohen was named a BTI Client Service All-Star by corporate counsel in recognition of his excellence in client service. From 2012-2014, he was selected by Super Lawyers to the New York-Metro Rising Stars list for Intellectual Property Litigation.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.